Gene · 4437
Papers3,191
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,201 to 1,220 of 3,191
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | ACS Chem Biol | 2020 | 32786267 | PubTator, text mining | PubMed |
| DNA Methylation as a Therapeutic Target for Bladder Cancer. | Cells | 2020 | 32784599 | PubTator, text mining | PubMed |
| DNA mismatch repair is not disrupted in stage 0 colorectal cancer resected using endoscopic submucosal dissection. | Oncol Lett | 2020 | 32782560 | PubTator, text mining | PubMed |
| ZZW-115-dependent inhibition of NUPR1 nuclear translocation sensitizes cancer cells to genotoxic agents. | JCI Insight | 2020 | 32780723 | PubTator, text mining | PubMed |
| Is elevated microsatellite alterations at selected tetranucleotide repeats (EMAST)-negative/MSI-high colorectal cancer a distinct subtype of the disease? | J Surg Oncol | 2020 | 32779222 | PubTator, text mining | PubMed |
| Potential of modern circulating cell-free DNA diagnostic tools for detection of specific tumour cells in clinical practice. | Biochem Med (Zagreb) | 2020 | 32774122 | PubTator, text mining | PubMed |
| The Pathologic and Molecular Landscape of Esophageal Squamous Cell Carcinogenesis. | Cancers (Basel) | 2020 | 32759723 | PubTator, text mining | PubMed |
| DNA Mismatch Repair Gene Variants in Sporadic Solid Cancers. | Int J Mol Sci | 2020 | 32756484 | PubTator, text mining | PubMed |
| An American patient with polyposis carrying a Scandinavian AXIN2 pathogenic variant. | Hered Cancer Clin Pract | 2020 | 32754288 | PubTator, text mining | PubMed |
| Genetic Variants in DNA Mismatch Repair Pathway predict prognosis of Lung Cancer patients with receiving Platinum-Based Chemotherapy. | J Cancer | 2020 | 32742474 | PubTator, text mining | PubMed |
| Crescents formations are independently associated with higher mortality in biopsy-confirmed immunoglobulin A nephropathy. | PLoS One | 2020 | 32735632 | PubTator, text mining | PubMed |
| Delineation of the Germline and Somatic Mutation Interaction Landscape in Triple-Negative and Non-Triple-Negative Breast Cancer. | Int J Genomics | 2020 | 32724790 | PubTator, text mining | PubMed |
| Integrated analysis revealing genome-wide chromosomal copy number variation in supraglottic laryngeal squamous cell carcinoma. | Oncol Lett | 2020 | 32724360 | PubTator, text mining | PubMed |
| Molecular Mechanisms Contributing Bacterial Infections to the Incidence of Various Types of Cancer. | Mediators Inflamm | 2020 | 32724295 | PubTator, text mining | PubMed |
| Identifying CpG methylation signature as a promising biomarker for recurrence and immunotherapy in non-small-cell lung carcinoma. | Aging (Albany NY) | 2020 | 32723974 | PubTator, text mining | PubMed |
| Gold Nanoparticles as a Potent Radiosensitizer: A Transdisciplinary Approach from Physics to Patient. | Cancers (Basel) | 2020 | 32718058 | PubTator, text mining | PubMed |
| Whole exome profiling and mutational analysis of Ocular Surface Squamous Neoplasia. | Ocul Surf | 2020 | 32717381 | PubTator, text mining | PubMed |
| Dianhydrogalactitol synergizes with topoisomerase poisons to overcome DNA repair activity in tumor cells. | Cell Death Dis | 2020 | 32709853 | PubTator, text mining | PubMed |
| The Effects of Genetic and Epigenetic Alterations of BARD1 on the Development of Non-Breast and Non-Gynecological Cancers. | Genes (Basel) | 2020 | 32708251 | PubTator, text mining | PubMed |
| Minireview Exploring the Biological Cycle of Vitamin B3 and Its Influence on Oxidative Stress: Further Molecular and Clinical Aspects. | Molecules | 2020 | 32707945 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4437/papers?page=61